Abstract: Patients having a clotting factor defect can be successfully treated by the administration of a composition containing effective hemostatic amounts of factor VIIa. Preferably, the factor VIIa is substantially free of factors IXa and Xa. Procedures for preparing the above therapeutic compositions are also described.

Abstract: Biological indicators are used to evaluate the effectiveness of virus inactivation conducted on virus-contaminated, protein-containing compositions. The indicators comprise dry protein and a predetermined titer of infectious virus.

Abstract: An improved hanger assembly is provided for use with bottles containing liquids, particularly glass vessels for holding liquids to be administered parenterally. The hanger includes a frangibly-activated hinge that biases the rotation of a hook or loop into a position to enable safe and expeditious hanging of the bottle. The assembly is a substantially rigid unitary construction made of material having a substantially uniform thickness, i.e., not having any elements protruding outside of the general profile of the bottle to be hung. The assembly maintains this profile until the frangibly-activated hinge is broken to allow rotation of the hook or loop into a position to permit hanging. Further, use of a frangibly-activated hinge permits the use of design and materials for the hanger assembly which reduce the risks of tearing the hanger and improve the bottle orientation when it is hung.

Abstract: Lipin particles are removed from aqueous suspension by adsorption on hydrophilic macromolecules substituted with pendant hydrophobic groups. Particularly beneficial results are achieved by use of pendant hydrophobes linked by strongly ionogenic groups to water insoluble carriers.

Abstract: Compounds useful as tracers in the radioimmunoassay of xanthine derivatives such as theophylline and pharmacologically related drugs: ##STR1## wherein at least one R.sub.1, R.sub.3, R.sub.7 or R.sub.8 is a radioiodinated radical and wherein, if not substituted by a radioiodinated radical, the remaining R.sub.1, R.sub.3, R.sub.7 or R.sub.8 groups are otherwise identical to the substituents at these positions in the xanthine derivative to be assayed. Ordinarily, R.sub.1 is hydrogen, acetate or methyl; R.sub.3 is methyl; R.sub.7 is hydrogen, acetate or methyl; and R.sub.8 is hydrogen. The tracers are made by linking radioiodinatable or preradioiodinated radicals to the xanthine derivative which is to be assayed. The tracers may be employed in known radioimmunoassay techniques.

Abstract: A p-nitrophenyl hydrolase contaminant present in Limulus coagulase sources interferes in, i.e., inhibits, coagulase-based assays for endotoxin. The contaminant inhibitor enzyme may be removed from coagulase by physical separation or by selective denaturation, for example by adjusting the pH of a coagulase solution to about from 8.5 to 11. Inhibitor-free coagulase is a novel composition. The coagulase activity of the composition is adjusted to a predetermined level to provide a standardized coagulase reagent for use in endotoxin assays.

Abstract: Nonspecific binding of radioiodinated protein hormones in specific-receptor binding assays is reduced by including a nonionic detergent with the tracer during storage prior to the assay.

Abstract: A composition comprising about from 37 to 190 units of factor VII/ml and about from 25 to 80 units of factor VIIa/ml is administered to patients in the treatment of clotting factor inhibitors. The composition may include activated and unactivated clotting factors such as factors IX, IXa, Xa and X.

Abstract: A novel amino acid composition is provided for the nutritional maintenance of renal failure patients.

Abstract: The green shade imparted to serum or plasma by biliverdin is eliminated by contacting the contaminated fluid with dithionite ion.

Abstract: The binding of vitamin B-12 by natural substances in samples assayed for vitamin B-12 is reduced by heating the test sample in an alkaline buffer comprising thioglycerol and denaturing agent having the formula (R).sub.2 NC(A)N(R).sub.2, wherein R is hydrogen or lower alkyl and A is oxygen or hydroxyl.

Abstract: An improved method and apparatus is disclosed for producing frozen particulate compositions from liquid feedstock. A continuous stream of liquid feedstock is passed through an orifice and into a liquid freezant without the orifice contacting the freezant. Compositions produced by this improved method have low proportions of fine and large particles, yielding particularly beneficial results in the case of quality control materials. The compositions are advantageously employed in automated weighing and filling apparatus.

Abstract: Compounds useful as tracers in the radioimmunoassay of xanthine derivatives such as theophylline and pharmacologically related drugs: ##STR1## Wherein at least one R.sub.1, R.sub.3, R.sub.7 or R.sub.8 is a radioiodinated radical and wherein, if not substituted by a radioiodinated radical, the remaining R.sub.1, R.sub.3, R.sub.7 or R.sub.8 groups are otherwise identical to the substituents at these positions in the xanthine derivative to be assayed. Ordinarily, R.sub.1 is hydrogen, acetate or methyl; R.sub.3 is methyl; R.sub.7 is hydrogen, acetate or methyl; and R.sub.8 is hydrogen. The tracers are made by linking radioiodinatable or preradioiodinated radicals to the xanthine derivative which is to be assayed. The tracers may be employed in known radioimmunoassay techniques.

Abstract: A system is provided for testing the sterility of a plurality of samples. The samples are fed by gravity to and through a first conduit which branches into a pair of conduits terminating in two separate test chambers. Each of the test chambers has a main chamber portion and a filter therein. The sample material is gravity fed into the main chamber portions and a vacuum pump is used to draw the liquid material through the filter and out of the test chamber. Test media is introduced to each of the test chambers through an injection site and the test chambers are incubated.

Abstract: Free analytes in samples containing free analytes and receptorbound analytes are determined by absorbing at least a portion of free analyte from the sample with insolubilized receptor or receptor which is then made insoluble, washing the insoluble receptor, adding labelled sample analyte or labelled sample analyte receptor, incubating, washing the insoluble phase free of the soluble phase and determining the label in either phase. The method solves a long standing need in the assay of free thyroid hormones.

Abstract: Test methods in which an enzyme conversion of at least one member of a family of compounds to an analyte precedes an immunoassay of the analyte are improved by conducting the enzyme conversion step substantially simultaneous with the immunoassay. A novel composition is provided for conducting the improved test method.

Abstract: The performance of double receptor, specific binding assays is improved by use of a receptor complex having the structureA.sub.BL (BL).sub.n A.sub.1wherein BL is a binding ligand, A.sub.BL is a receptor specific for binding ligand, A.sub.1 is a receptor, BL is covalently bonded to A.sub.1 and A.sub.BL is reversibly bonded to BL. Generally A.sub.BL is absorbed onto an insoluble surface and A.sub.1 is an antibody to the substance being assayed. The complex has particular utility in coated tube and rechargeable radioimmunoassay systems.

Abstract: Prostatic acid phosphatase is immunologically unstable under typical laboratory conditions. Thus it is necessary to combine a stabilizing composition with samples taken for immunological assay of prostatic acid phosphatase content, and to similarly stabilize prostatic acid phosphatase-containing reagents in kits used to assay the enzyme.

Abstract: Samples are extracted with organic solvents and the organic solvents are then placed directly into antiserum coated test tubes and dried. The improved method combines steps heretofore performed separately, resulting in improved assay convenience, cost and accuracy.

Abstract: A method of synthesizing fluoromethylhexafluoroisopropyl ether comprises adding hexafluoroisopropyl alcohol to a mixture comprising a stoichiometric excess of paraformaldehyde and hydrogen fluoride, plus sufficient sulfuric acid to sequester most of the water produced by the reaction. The mixture is maintained at a temperature of at least 57.degree. C., to cause vapor formation by boiling of the fluoromethylhexafluoroisopropyl ether formed. The vapor is then collected and condensed, and may be purified by distillation.